BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights

BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights

Abstract This study investigates Bacillus Calmette‐Guérin (BCG) as a potential treatment for hepatocellular carcinoma (HCC), a condition often associated with unfavorable treatment outcomes. Exploiting BCG's recognized immune‐boosting properties, preclinical trials are conducted using HCC mice,...

Full description

Bibliographic Details
Main Authors: Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu‐Jui Yvonne Wan
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Advanced Science
Subjects:
bacterial immunotherapy
fibrosis
interferon
liver
trained immunity
Online Access:https://doi.org/10.1002/advs.202308242

Internet

https://doi.org/10.1002/advs.202308242

Similar Items